
    
      To evaluate the efficacy and safety of oral propolis as an adjunct treatment for SARS-CoV-2
      infection, we designed a randomized, double-blind, placebo-controlled trial (Bee-Covid2) (The
      Use of Brazilian Green Propolis Extract (EPP-AFÂ®) in Patients Affected by COVID-19).
    
  